The Rha-binding activity of rHPL may contribute to the growth inhibitory effect on P. aeruginosa. Recently, drugs targeting cell wall synthesis, and thus Rha synthesis, in M. tuberculosis have been studied as possible clinical agents to treat tuberculosis [35]. This evidence concerns the gene DHX9 and tuberculosis.